| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/01/2006 | EP1620082A2 Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | CN1729177A New uracils having a herbicidal activity |
| 02/01/2006 | CN1729171A Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/01/2006 | CN1239498C Substituted pyrrolidines as CCR-3 receptor antagonists |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992097 such as methyl-1-{2-[4-((2R)-2-{2-[(tert-butoxy)carbonylamino]-2-methylpropanoylamino}-3-indol-3-ylpropanoylamino)imidazolyl]-2-phenylacetyl}pyrrolidine-2-carboxylate |
| 01/31/2006 | US6992087 Substituted aryl 1,4-pyrazine derivatives |
| 01/31/2006 | US6992044 Substituted phenyluracils |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006009819A1 Inhibitors of cholesteryl ester transfer protien |
| 01/26/2006 | WO2006009736A1 Processes for preparing gonadotropin releasing hormone receptor antagonists |
| 01/26/2006 | WO2006009726A2 Substituted urea derivatives for treating cardiac diseases |
| 01/26/2006 | WO2006009653A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | WO2006009325A1 Metalloprotease inhibitor |
| 01/26/2006 | WO2006008644A1 Antidiabetic compounds |
| 01/26/2006 | WO2006008259A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 01/26/2006 | WO2006008196A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |
| 01/26/2006 | WO2005111020A3 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4 |
| 01/26/2006 | WO2005097134A3 Quinazoline based protein kinase inhibitors |
| 01/26/2006 | US20060020132 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence |
| 01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 01/26/2006 | US20060020013 Control of arthropods in animals |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060020011 Diseases mediated by tachykinins and for seritonin reuptake transporter protein as reuptake inhibitors |
| 01/26/2006 | US20060020010 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/26/2006 | US20060020006 less side effects; higher potency; chronic and neuropathic pain, epilepsy, manic depression, bipolar disorder, diabetic neuropathy; 3-[3-(2-Trifluoromethoxyphenyl)-phenyl]-1,2,4-triazole |
| 01/26/2006 | US20060020005 Process for preparing losartan |
| 01/26/2006 | US20060020003 Biphenyloxy-acids |
| 01/26/2006 | US20060020000 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 01/26/2006 | US20060019997 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 01/26/2006 | US20060019975 Novel piperidyl derivatives of quinazoline and isoquinoline |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019973 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 01/26/2006 | US20060019965 Gonadotropin releasing hormone receptor antagonists |
| 01/26/2006 | US20060019964 Compounds |
| 01/26/2006 | US20060019962 Modulators of muscarinic receptors |
| 01/26/2006 | US20060019953 Pyridine inhibitors of ERK2 and uses thereof |
| 01/26/2006 | US20060019946 3-(4-Piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one |
| 01/26/2006 | US20060019831 1-(3-trifluoromethyl)phenyl-3-(N-methyl)carboxamido-2-pyrrolidinone; herbicides; high compatibility with crop plants is desirable; no adverse effect on the chlorophyll synthesis in crop plants; crop protection compositions |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 01/26/2006 | US20060016027 Substituted diketone anthracylaminobenzene linked to another benzene through a diaminochloro-1,3,5-triazine; uniform colour build-up, good affinity, fixing ability, good constancy of shade even at different concentrations, good fastness; printing cellulose, polyamides |
| 01/26/2006 | US20060016025 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
| 01/26/2006 | DE112004000331T5 Neue Verbindung und Zusammensetzung, hergestellt unter Verwendung einer solchen Verbindung New compound and composition prepared by using such a compound |
| 01/26/2006 | CA2579724A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 01/26/2006 | CA2574666A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |
| 01/26/2006 | CA2573210A1 Viral polymerase inhibitors |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | CA2572821A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/26/2006 | CA2570693A1 Processes for preparing gonadotropin releasing hormone receptor antagonists |
| 01/25/2006 | EP1618105A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| 01/25/2006 | EP1618104A1 Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives |
| 01/25/2006 | EP1618099A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 01/25/2006 | EP1618094A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 01/25/2006 | EP1618093A2 Indazole derivatives as jnk inhibitors |
| 01/25/2006 | EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1212318B1 Substituted indolinones as tyrosine kinase inhibitors |
| 01/25/2006 | EP0978392B1 Optical recording media |
| 01/25/2006 | EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726210A Novel compounds having selective inhibiting effect at GSK3 |
| 01/25/2006 | CN1726206A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 01/25/2006 | CN1726196A Pyrazine-based tubulin inhibitors |
| 01/25/2006 | CN1726194A Novel compounds |
| 01/25/2006 | CN1726191A Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/25/2006 | CN1726042A Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 01/25/2006 | CN1238343C Pyrimidine derivatives and herbicides containing the same |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | US6989383 Method of treating cancer |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | CA2352392C Eletriptan hydrobromide monohydrate |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2166415C Acylated aminophenylsulfonylureas; preparation and use as herbicides and plant growth regulators |
| 01/24/2006 | CA2123093C Sulfonamide herbicides |
| 01/19/2006 | WO2006005918A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005915A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005914A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005571A1 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi |
| 01/19/2006 | WO2005099705A3 Preparation of imidazole derivatives and methods of use |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | US20060014966 Cell adhesion inhibitors |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014817 CCK-1 receptor modulators |
| 01/19/2006 | US20060014801 Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs |
| 01/19/2006 | US20060014800 Naphthalene derivatives and active compounds; interactions between the compounds and certain amino acid residues in the binding pocket of the Retinoid Nuclear receptors; interact with cellular receptors; useful in modulation of gene expression; enhanced in vitro profiles compared to known compounds |
| 01/19/2006 | US20060014798 Forming compounds with oxidation using hydrogen peroxide to form sulfur oxide for antisecretory agents of gastric juice |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014785 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| 01/19/2006 | US20060014761 Compounds, compositions and methods |
| 01/19/2006 | US20060014756 Benzimidazoles |